Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
MID1IP1 Antibody, Novus Biologicals™
Rabbit Polyclonal Antibody
Supplier: Novus Biologicals NBP132599
Description
MID1IP1 Polyclonal specifically detects MID1IP1 in Human samples. It is validated for Western Blot, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry-Paraffin.Specifications
MID1IP1 | |
Polyclonal | |
Unconjugated | |
0.1M Tris (pH 7.0), 0.1M Glycine and 10% Glycerol with 0.01% Thimerosal | |
FLJ10386, G12-like, Gastrulation-specific G12-like protein, MID1 interacting protein 1 (gastrulation specific G12 homolog (zebrafish)), MID1 interacting protein 1 (gastrulation specific G12-like (zebrafish)), MID1 interacting protein 1 (gastrulation specific G12-like), Mid1-interacting G12-like protein, mid1-interacting protein 1, MIG12MID1 interacting G12-like protein, Protein STRAIT11499, S14R, Spot 14-R, Spot 14-related protein, STRAIT11499, THRSPL | |
Rabbit | |
20 kDa | |
0.1 mL | |
Core ESC Like Genes, Stem Cell Markers | |
58526 | |
Human | |
IgG |
Western Blot, Immunohistochemistry, Immunocytochemistry, Immunofluorescence, Immunohistochemistry (Paraffin) | |
0.68mg/mL | |
Western Blot 1:500-1:3000, Immunohistochemistry 1:100-1:1000, Immunocytochemistry/Immunofluorescence 1:100-1:1000, Immunohistochemistry-Paraffin 1:100-1:1000 | |
Q9NPA3 | |
MID1IP1 | |
Recombinant protein encompassing a sequence within the center region of human MID1IP1. The exact sequence is proprietary. | |
Affinity Purified | |
RUO | |
Primary | |
Human. Predicted cross-reactivity based on sequence identity: Bovine (93%). | |
Aliquot and store at -20C or -80C. Avoid freeze-thaw cycles. |
Provide Content Correction
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?
Provide Content Correction